Boston Scientific EPS - Earnings per Share 2012-2025 | BSX
Boston Scientific annual and quarterly earnings per share history from 2012 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Boston Scientific EPS for the quarter ending September 30, 2025 was $0.51, a 59.38% increase year-over-year.
- Boston Scientific EPS for the twelve months ending September 30, 2025 was $1.87, a 54.55% increase year-over-year.
- Boston Scientific 2024 annual EPS was $1.25, a 16.82% increase from 2023.
- Boston Scientific 2023 annual EPS was $1.07, a 137.78% increase from 2022.
- Boston Scientific 2022 annual EPS was $0.45, a 34.78% decline from 2021.
| Boston Scientific Annual EPS | |
|---|---|
| 2024 | $1.25 |
| 2023 | $1.07 |
| 2022 | $0.45 |
| 2021 | $0.69 |
| 2020 | $-0.08 |
| 2019 | $3.33 |
| 2018 | $1.19 |
| 2017 | $0.08 |
| 2016 | $0.25 |
| 2015 | $-0.18 |
| 2014 | $-0.09 |
| 2013 | $-0.09 |
| 2012 | $-2.89 |
| 2011 | $0.29 |
| Boston Scientific Quarterly EPS | |
|---|---|
| 2025-09-30 | $0.51 |
| 2025-06-30 | $0.53 |
| 2025-03-31 | $0.45 |
| 2024-12-31 | $0.38 |
| 2024-09-30 | $0.32 |
| 2024-06-30 | $0.22 |
| 2024-03-31 | $0.33 |
| 2023-12-31 | $0.34 |
| 2023-09-30 | $0.34 |
| 2023-06-30 | $0.18 |
| 2023-03-31 | $0.21 |
| 2022-12-31 | $0.09 |
| 2022-09-30 | $0.12 |
| 2022-06-30 | $0.17 |
| 2022-03-31 | $0.07 |
| 2021-12-31 | $0.06 |
| 2021-09-30 | $0.28 |
| 2021-06-30 | $0.12 |
| 2021-03-31 | $0.23 |
| 2020-12-31 | $0.14 |
| 2020-09-30 | $-0.12 |
| 2020-06-30 | $-0.11 |
| 2020-03-31 | $0.01 |
| 2019-12-31 | $2.83 |
| 2019-09-30 | $0.09 |
| 2019-06-30 | $0.11 |
| 2019-03-31 | $0.30 |
| 2018-12-31 | $0.27 |
| 2018-09-30 | $0.31 |
| 2018-06-30 | $0.40 |
| 2018-03-31 | $0.21 |
| 2017-12-31 | $-0.44 |
| 2017-09-30 | $0.20 |
| 2017-06-30 | $0.11 |
| 2017-03-31 | $0.21 |
| 2016-12-31 | $0.08 |
| 2016-09-30 | $0.17 |
| 2016-06-30 | $-0.15 |
| 2016-03-31 | $0.15 |
| 2015-12-31 | $-0.11 |
| 2015-09-30 | $-0.15 |
| 2015-06-30 | $0.08 |
| 2015-03-31 | $0.00 |
| 2014-12-31 | $-0.22 |
| 2014-09-30 | $0.03 |
| 2014-06-30 | $0.00 |
| 2014-03-31 | $0.10 |
| 2013-12-31 | $0.07 |
| 2013-09-30 | $0.00 |
| 2013-06-30 | $0.10 |
| 2013-03-31 | $-0.26 |
| 2012-12-31 | $0.02 |
| 2012-09-30 | $-0.48 |
| 2012-06-30 | $-2.51 |
| 2012-03-31 | $0.08 |
| 2011-12-31 | $0.07 |
| 2011-09-30 | $0.09 |
| 2011-06-30 | $0.10 |
| 2011-03-31 | $0.03 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $139.557B | $16.747B |
| Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $216.142B | 24.91 |
| EssilorLuxottica (ESLOY) | France | $149.893B | 0.00 |
| Stryker (SYK) | United States | $136.074B | 27.02 |
| Medtronic (MDT) | Ireland | $123.612B | 17.13 |
| Medline (MDLN) | United States | $56.293B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.245B | 0.00 |
| Agilent Technologies (A) | United States | $41.482B | 26.22 |
| GE HealthCare Technologies (GEHC) | United States | $38.615B | 18.47 |
| ResMed (RMD) | United States | $37.167B | 25.72 |
| Koninklijke Philips (PHG) | Netherlands | $28.531B | 18.64 |
| Terumo (TRUMY) | Japan | $21.128B | 23.78 |
| Insulet (PODD) | United States | $19.568B | 60.74 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.507B | 10.92 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.553B | 0.00 |
| Baxter (BAX) | United States | $10.101B | 8.15 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.690B | 31.25 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| BillionToOne (BLLN) | United States | $4.433B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.366B | 13.30 |
| Envista Holdings (NVST) | United States | $3.820B | 21.92 |
| Haemonetics (HAE) | United States | $3.690B | 16.42 |
| ICU Medical (ICUI) | United States | $3.661B | 23.24 |
| Prestige Consumer Healthcare (PBH) | United States | $3.111B | 14.19 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.262B | 14.54 |
| Perrigo (PRGO) | Ireland | $2.073B | 5.19 |
| Neogen (NEOG) | United States | $1.999B | 43.76 |
| LeMaitre Vascular (LMAT) | United States | $1.891B | 38.06 |
| AtriCure (ATRC) | United States | $1.810B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.784B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.742B | 76.36 |
| Phibro Animal Health (PAHC) | United States | $1.640B | 16.38 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.515B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.437B | 20.80 |
| Kestra Medical Technologies (KMTS) | United States | $1.286B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.151B | 341.43 |
| Capricor Therapeutics (CAPR) | United States | $1.133B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.054B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.028B | 0.00 |
| Omeros (OMER) | United States | $0.895B | 0.00 |
| InMode (INMD) | Israel | $0.887B | 10.02 |
| Valneva SE (VALN) | France | $0.864B | 0.00 |
| CeriBell (CBLL) | United States | $0.845B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.564B | 15.30 |
| Cerus (CERS) | United States | $0.484B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.476B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.472B | 0.00 |
| Brainsway (BWAY) | Israel | $0.467B | 79.45 |
| Canopy Growth (CGC) | Canada | $0.461B | 0.00 |
| SNDL (SNDL) | Canada | $0.434B | 0.00 |
| Evolus (EOLS) | United States | $0.371B | 0.00 |
| Quanterix (QTRX) | United States | $0.334B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.295B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 21.97 |
| Sanuwave Health (SNWV) | United States | $0.245B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.33 |
| TerrAscend (TSNDF) | Canada | $0.236B | 0.00 |
| High Tide (HITI) | Canada | $0.235B | 0.00 |
| Organigram Global (OGI) | Canada | $0.228B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanara MedTech (SMTI) | United States | $0.211B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.197B | 0.00 |
| Accendra Health (ACH) | United States | $0.194B | 1.95 |
| Utah Medical Products (UTMD) | United States | $0.188B | 16.54 |
| OraSure Technologies (OSUR) | United States | $0.187B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.135B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.117B | 0.00 |
| Exagen (XGN) | United States | $0.117B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.76 |
| Biote (BTMD) | United States | $0.111B | 4.86 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Sharps Technology (STSS) | United States | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.58 |
| Nephros (NEPH) | United States | $0.047B | 34.00 |
| Cytosorbents (CTSO) | United States | $0.046B | 0.00 |
| Veru (VERU) | United States | $0.039B | 0.00 |
| Jin Medical (ZJYL) | China | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.57 |
| Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Bonk (BNKK) | United States | $0.014B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |